SCHEMBL20049334

SCHEMBL20049334

Cc1nc2ncc(CC(C)C)nc2s1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.35
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14970054 0.72 HSD17B10 (0.33)
SCHEMBL6466753 0.71 NOS3 (0.40) NOS3NOS1NOS2
SCHEMBL31696345 0.69 USP2 (0.32)
SCHEMBL7990997 0.69 USP2 (0.32)
SCHEMBL1673946 0.69 USP2 (0.32)
SCHEMBL31374320 0.69 NOS3 (0.41) NOS3NOS1NOS2
SCHEMBL9953928 0.69 NOS3 (0.41) NOS3NOS1NOS2
SCHEMBL23643784 0.67 POLB (0.41)
SCHEMBL16268335 0.67 USP2 (0.33)
SCHEMBL6844986 0.67 KDM4E (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067704-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-04-12 WO disclosed